VEGFA and cholangiocarcinoma: Meanwhile, SEZ6L2 may upregulate the expression of PDGF, VEGF, and VEGF receptors through positive feedback regulation, thus ultimately promoting the angiogenesis of cholangiocarcinoma [32].